HeartFlow, Inc.
Pharmaceutical & medical device company payment data from CMS Open Payments.
Total Payments
$13.5M
Doctors Paid
9,758
Transactions
24,704
2024 Total
$1.9M
Payment Breakdown by Category
Research$9.2M (68.1%)
Consulting$1.9M (13.7%)
Food & Beverage$1.2M (8.7%)
Travel$296,831 (2.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $9.2M | 603 | 68.1% |
| Consulting Fee | $1.9M | 647 | 13.7% |
| Food and Beverage | $1.2M | 21,859 | 8.7% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $787,647 | 465 | 5.8% |
| Travel and Lodging | $296,831 | 1,080 | 2.2% |
| Education | $148,750 | 24 | 1.1% |
| Space rental or facility fees (teaching hospital only) | $21,000 | 10 | 0.2% |
| Grant | $13,000 | 4 | 0.1% |
| Entertainment | $654.34 | 7 | 0.0% |
| Honoraria | $249.80 | 4 | 0.0% |
| Gift | $83.55 | 1 | 0.0% |
Payments by Type
Research
$9.2M
524 transactions
General
$4.3M
24,101 transactions
Ownership
$0
79 transactions
Research Studies & Clinical Trials
| Study Name | Total Paid | Doctors | Records |
|---|---|---|---|
| Assessing Diagnostic Value of Non-invasive FFRCT in Coronary Care | $3.2M | 0 | 133 |
| 100 Analysis : 200 FFRct Analysis : 400 Clinical Studies : 424 PRECISE | $2.0M | 0 | 187 |
| 100 Analysis : 200 FFRct Analysis : 400 Clinical Studies : 438 JACS | $890,682 | 0 | 29 |
| Prospective Randomized Trial of Optimal Evaluation of Suspected Coronary Artery Disease | $654,643 | 0 | 5 |
| RetrospectivE study of FFRCT compared to mFFR and CTA In the post-market ENvironmEnt | $356,268 | 0 | 8 |
| Precise Study | $267,144 | 0 | 32 |
| Evaluation of FFRCT to improve efficacy and efficiency of management of Patients With Acute Chest Pain as compared to anatomic CCTA and Standard of Care | $245,460 | 0 | 3 |
| 100 Analysis : 200 FFRct Analysis : 400 Clinical Studies : 447 REVEALPLAQUE | $184,335 | 0 | 21 |
| REFINE Cardiovascular Imaging Core Lab. | $183,688 | 0 | 1 |
| 100 Analysis : 200 FFRct Analysis : 400 Clinical Studies : 448 MGH Type 2 MI | $168,551 | 0 | 6 |
| PRECISE, C6000136 Protocol #CP-907-001-A PI: Victor Marinnescu, MD | $160,300 | 0 | 7 |
| AI DErived Plaque Quantification: CCTA and AI-QCPA for Determining Effective CAD Management (DECIDE) | $114,550 | 0 | 17 |
| PRECISE, C6000148 Protocol #CP-907-001-A PI: Sorin Danciu, MD, | $102,250 | 0 | 1 |
| Prospective Randomized Trial of the Optimal Evaluation of Cardiac Symptoms and Revascularization (PRECISE) | $95,895 | 0 | 21 |
| Promise - CT - FFR Cost Effectiveness Analysis | $89,560 | 0 | 1 |
| SPECT vs CT vs. FFRCT: Diagnostic accuracy (using FFRCT as gold standard) | $78,576 | 0 | 4 |
| 100 Analysis : 200 FFRct Analysis : 400 Clinical Studies : 437 P3 | $69,500 | 0 | 1 |
| 100 Analysis : 200 FFRct Analysis : 400 Clinical Studies : 442 FFRct ACP | $64,800 | 0 | 2 |
| 100 Analysis : 200 FFRct Analysis : 400 Clinical Studies : 443 ADVANCE-ED | $52,640 | 0 | 8 |
| "The AFFECTS Study: Assessment of Fractional Flow reservE Computed Tomography versus Single photon emission computed tomography in the diagnosis of hemodynamically significant coronary artery disease " | $46,464 | 0 | 5 |
| The AFFECTS Study: Assessment of Fractional Flow reservE Computed Tomography versus | $42,079 | 0 | 5 |
| 100 Analysis : 200 FFRct Analysis : 201 FFRct (Default) | $30,150 | 0 | 2 |
| PRECISE, C6000136 Protocol #CP-907-001-A PI: Victor Marinescu, MD, | $29,550 | 0 | 3 |
| Assessing Diagnostic Value of Non-invasive FFRCT in Coronary CarE | $12,848 | 0 | 3 |
| PRECISE CP-907-001-A - IRB FEE | $12,500 | 0 | 1 |
| Prospective Randomized Trial of the Optimal Evaluation of Cardiac Symptoms and Revascularizaton -Protocol CP-907-001-A | $12,094 | 0 | 3 |
| PRECISE Protocol #CP-907-001-A | $11,000 | 0 | 1 |
| Precise Study -CP-907-001-A | $7,813 | 0 | 2 |
| CP-907-001-A PRECISE | $7,700 | 0 | 1 |
| PRECISE CP-907-001-A | $6,350 | 0 | 1 |
Payments by Medical Specialty
Top Paid Doctors — Page 2
| Doctor | Specialty | Location | Total | 2024 |
|---|---|---|---|---|
| Moneal Shah, Md, MD | Internal Medicine | Pittsburgh, PA | $25,280 | $0 |
| Seth Martin | Cardiovascular Disease | Baltimore, MD | $24,404 | $0 |
| Dr. Payal Kohli, M.d, M.D | Internal Medicine | Aurora, CO | $23,839 | $0 |
| Dr. Madhavi Kadiyala, Md, MD | Cardiovascular Disease | Morgantown, WV | $23,346 | $0 |
| Jennifer Abitabilo, Apn-C, APN-C | Family | Hasbrouck Heights, NJ | $22,818 | $0 |
| Dr. Eric Flagg, M.d, M.D | Diagnostic Radiology | Burlingame, CA | $22,544 | $0 |
| Steven Raible, Md, MD | Cardiovascular Disease | Louisville, KY | $22,404 | $0 |
| Ron Blankstein, M.d, M.D | Cardiovascular Disease | Boston, MA | $21,812 | $0 |
| Dr. Colin Barker, M.d, M.D | Cardiovascular Disease | Nashville, TN | $21,573 | $0 |
| Dr. Sujith Kalathiveetil, M.d, M.D | Cardiovascular Disease | Naperville, IL | $21,497 | $0 |
| Morton Kern, Md, MD | Cardiovascular Disease | Orange, CA | $18,921 | $0 |
| Sachin Malik, Md, MD | Diagnostic Radiology | Stanford, CA | $17,000 | $0 |
| Dr. Ziad Ali, Md Dphil, MD DPHIL | Internal Medicine | New York, NY | $16,943 | $0 |
| Dr. Neerav Sheth, Md, MD | Cardiovascular Disease | Paoli, PA | $16,131 | $0 |
| Fatima Rodriguez, Md, MD | Internal Medicine | Stanford, CA | $14,609 | $0 |
| Dr. Omar Khalique, Md, MD | Clinical Cardiac Electrophysiology | New York, NY | $14,356 | $0 |
| Dr. Jonathan Spagnola, Md, MD | Internal Medicine | Staten Island, NY | $13,853 | $0 |
| Unknown Provider | — | — | $13,500 | $0 |
| Unknown Provider | — | — | $13,131 | $0 |
| Dr. Roosha Parikh, M.d, M.D | Cardiovascular Disease | Roslyn, NY | $12,790 | $0 |
| Melany Atkins, M.d, M.D | Diagnostic Radiology | Fairfax, VA | $12,569 | $0 |
| Dr. Varinder Singh, M.d, M.D | Cardiovascular Disease | New York, NY | $11,612 | $0 |
| Dr. Frederick St. Goar, M.d, M.D | Interventional Cardiology | Mountain View, CA | $10,901 | $0 |
| Kendall Allred, M.d., M.p.h, M.D., M.P.H | Emergency Medicine | Burlingame, CA | $10,000 | $0 |
| Lynne Koweek, Md, MD | Diagnostic Radiology | Durham, NC | $9,911 | $0 |
About HeartFlow, Inc.
HeartFlow, Inc. has made $13.5M in payments to 9,758 healthcare providers, recorded across 24,704 transactions in the CMS Open Payments database. In 2024, the company paid $1.9M. The top product by payment volume is FFRct ($9.1M).
Payments were distributed across 126 medical specialties. The top specialty by payment amount is Cardiovascular Disease ($2.2M to 3,323 doctors).
Payment categories include: Food & Beverage ($1.2M), Consulting ($1.9M), Research ($9.2M), Travel & Lodging ($296,831).
HeartFlow, Inc. is associated with 1 products in the CMS Open Payments database.